Author | F. Zorat


Encouraging Improvement in Cytopenias of Patients With Myelodysplastic Syndromes With Thalidomide

November 01, 2000

ByA. Raza|L. Lisak|C. Anderews|L. Little|F. Zorat|V. Shetty|S. Alvi|S. Mundle|K. Allampallam|M. duRant|M. Ekbal|M. Muzammil

Myelodysplastic syndrome patients present with variable cytopenias even though their bone marrows are generally hypercellular. Excessive cytokine-induced apoptosis of hematopoietic cells in the marrows has been proposed as a possible